Adaptive Biotechnologies vs Lydiarx

Adaptive Biotechnologies vs Lydiarx, compared side by side on 9 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Adaptive Biotechnologies is on 69/100 and Lydiarx on 2/100.

Adaptive Biotechnologies logo
Adaptive BiotechnologiesLeveraging the adaptive immune system to diagnose and treat disease.
Try Adaptive Biotechnologies
Lydiarx logo
LydiarxLydiaRx provides AI-native platforms to modernize pharmaceutical operations from drug discovery through distribution, focusing on regulated environments.
Try Lydiarx

Where each one leads

Adaptive Biotechnologies

  • our overall score: 69/100 against 2/100

Lydiarx

  • agent readiness: 50/100 against 39/100

At a glance

MeasureAdaptive BiotechnologiesLydiarx
What it isLeveraging the adaptive immune system to diagnose and treat disease.LydiaRx provides AI-native platforms to modernize pharmaceutical operations from drug discovery through distribution, focusing on regulated environments.
CategoryBiotech, HealthTech, Genomics, Drug DiscoveryHealthTech, Biotech, MedTech, Pharmaceutical R&D
Sells toBusiness modelB2BB2B
OfferingSoftware | services | platformPlatform
Founded20092026
HeadquartersSeattle, United StatesLondon, United Kingdom
StatusActiveActive

Size, funding and growth

MeasureAdaptive BiotechnologiesLydiarx
Total funding$300MNot published
Latest roundSeries DNot published

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureAdaptive BiotechnologiesLydiarx
StartupHub scoreOur 0-100 rating69/1002/100
Agent readinessHow well an AI agent can read and act on the siteF (39/100)D (50/100)
Domain ratingLink authority, 0-10062/100Not published

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureAdaptive BiotechnologiesLydiarx
HostingSelf ManagedNot detected
CMSWordPressNot detected
FrameworksJqueryNot detected
AnalyticsGoogle Tag ManagerNot detected

Adaptive Biotechnologies vs Lydiarx: common questions

Which is better, Adaptive Biotechnologies or Lydiarx?

On our 0-100 score Adaptive Biotechnologies rates higher (69/100 against 2/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 9 data points above: read the rows that match what you are buying for.

How do Adaptive Biotechnologies and Lydiarx compare on the numbers?

Adaptive Biotechnologies leads on our overall score (69/100 against 2/100). Lydiarx leads on agent readiness (50/100 against 39/100).

Read the full Adaptive Biotechnologies review and pricing or the Lydiarx review and pricing. You can also browse other Adaptive Biotechnologies alternatives we track.